Clinical Trial Update: Efficacy of BLIS K12 as Preventive Measure for Rheumatic Children [NA]

View source ↗

Summary

Clinical trial update evaluating BLIS K12 for prevention of rheumatic fever in children; current status of results is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatic Fever

Drugs mentioned

• BLIS K12 (Streptococcus salivarius K12)

Snippet

Sponsor: Kaplan Medical Center | Conditions: Rheumatic Fever | NA | Status: UNKNOWN